Imagine identical twin sisters who begin life with almost the same DNA. One develops painful, disproportionate changes in subcutaneous fat tissue in the legs and perhaps the arms. The other does not. For researchers, that difference is not an oddity to dismiss — it is a clue.
Lipedema is still an area with major diagnostic and biological uncertainty. The strongest current evidence supports a chronic disorder of subcutaneous adipose tissue, predominantly in women, with bilateral and symmetrical enlargement of affected limbs together with pain or discomfort. It should not be reduced to “fluid in the legs”, even though swelling and lymphatic or microvascular changes can coexist.
Quick answer
Do identical twins prove whether lipedema is genetic or environmental?
No. Affected identical twins support a genetic contribution, while a reported discordant identical-twin case shows that nearly identical inherited DNA is not necessarily sufficient. Together they make a strong case for larger, systematic twin studies — not for a simple gene-versus-environment answer.
Key takeaways
- Family clustering and genetic studies support inherited susceptibility in at least some lipedema, but no single universal “lipedema gene” has been established.
- A 2024 family sequencing study included an affected identical-twin pair but found no single likely disease-causing gene across all nine families.
- A 2025 congress case described an identical-twin pair in which only one sister had clinical lipedema; this is intriguing but cannot establish causation.
- Hormonal biology is plausible and actively studied, but puberty, pregnancy or menopause should not be described as proven causes.
- Exercise may improve symptoms and function, while diet evidence remains too limited to identify one best dietary pattern or a cure.
What lipedema is — and what it is not
The 2026 Lipedema World Alliance consensus describes lipedema as a chronic disorder involving subcutaneous adipose tissue, usually with bilateral, symmetrical enlargement of the extremities and pain or discomfort. Hands and feet are typically relatively spared. Diagnosis remains clinical and can overlap with obesity, lymphedema and other conditions.
Prevalence is one of the clearest examples of uncertainty. Published estimates range widely, and the consensus explicitly notes that the true prevalence in adult women is unknown. That makes confident population claims inappropriate.
Two twin observations that point in opposite — but compatible — directions
In 2024, a family-based whole-exome sequencing study analysed 31 people from nine families and included an identical-twin pair in which both twins were affected. The researchers found hundreds of candidate genes but no single likely disease-causing variant shared across all families. That fits a genetically heterogeneous picture rather than one simple Mendelian explanation.
In contrast, a 2025 congress report described an identical-twin pair in which one sister had clinically clear lipedema while the other had no clinical signs despite having had two children. One case cannot tell us what caused the difference. It does, however, define the kind of discordant pair that a rigorous co-twin study could investigate.
Hormones are biologically plausible, but causation is not settled
Lipedema overwhelmingly affects women and is often reported to emerge or change around reproductive transitions. A 2026 systematic review found hypotheses involving estrogen metabolism and receptors, growth hormone, adipose-cell metabolism, adipokines and related signalling. These mechanisms are scientifically plausible, but the review was based on only 15 included publications.
The responsible wording is therefore “hormonally influenced” or “hormonal mechanisms are under investigation”, not “estrogen causes lipedema”. Twin pairs who differ in reproductive history, hormone exposure or disease expression could be especially informative.
What exercise and diet research can — and cannot — say
A systematic exercise review published online in 2025 identified six studies with 115 women. Exercise appeared to improve pain and other symptoms, quality of life, limb measures and physical function, with some studies suggesting larger effects when compression was also used. The evidence is promising but too small and heterogeneous to define one best training prescription.
A 2024 randomized trial in 70 women with lipedema and obesity found greater weight loss and a larger reduction in current pain with an energy-restricted low-carbohydrate diet than with an energy-restricted control diet over eight weeks. A 2025 systematic review of diet studies still concluded that the overall evidence is too heterogeneous to determine an optimal diet. Neither exercise nor diet should be marketed as a cure.
The missing experiment: a large lipedema twin study
The major gap is striking: there is still no large classical twin study systematically comparing many monozygotic and dizygotic pairs with well-phenotyped lipedema. Such a study could estimate familial and genetic contributions more robustly and then focus on discordant identical pairs.
Those pairs could be compared for epigenetics, reproductive history, hormone exposure, metabolic health, physical activity, body composition, adipose and connective-tissue biology and other individual exposures. Every observed difference would still need careful causal testing, but the twin design would greatly narrow the search.
TwinPare perspective: the differences may be the most valuable data
Twin research is powerful because twins are not only similar. The scientifically interesting moment often comes when two people with an unusually similar genetic starting point become different.
For lipedema, an affected pair can strengthen the case for inherited susceptibility. A discordant pair can illuminate what genetics alone does not explain. Both observations belong in the same research story — and both argue for better studies rather than simpler claims.
Source notes
The sources have been verified and editorially reviewed for this article. The limitations below show which level of conclusion the sources support.
- [kruppa-2026] Lipedema World Alliance Delphi Consensus-Based Position Paper on the Definition and Management of Lipedema Philipp Kruppa et al.. Nature Communications, 2026. Evidence type: International Delphi consensus and position paper Limitation: The consensus supports a chronic painful adipose-tissue disorder and hereditary contribution in at least some cases, while emphasizing uncertainty around prevalence and several mechanisms. PubMed PMC DOI
- [morgan-2024] A Family-Based Study of Inherited Genetic Risk in Lipedema Steven Morgan et al.. Lymphatic Research and Biology, 2024. Evidence type: Whole-exome sequencing study of 31 people from nine lipedema families Limitation: Included the first reported lipedema-affected monozygotic twin pair in this literature. No single likely disease-causing gene was shared across all families, supporting genetic heterogeneity. PubMed PMC DOI
- [goerg-2025] Lipoedema and monovular twins. Genotype versus phenotype Anette Goerg. JDDG congress proceedings / 5th International Lymphology Symposium, 2025. Evidence type: Single clinical case presented in congress proceedings Limitation: An identical twin with clinical lipedema was described while her co-twin, who had had two children, had no clinical signs. This is a hypothesis-generating case, not evidence of causation. PubMed
- [luchinger-2026] Impact of hormones on lipedema development: a systematic literature review Julia Elisabeth Lüchinger et al.. Archives of Gynecology and Obstetrics, 2026. Evidence type: Systematic literature review; 15 included publications Limitation: The review identified hormonal and metabolic hypotheses, especially involving estrogen-related biology, but the underlying evidence remains limited and heterogeneous. PubMed PMC DOI
- [lanzi-2025] Exercise training in women with lipedema - A systematic review Stefano Lanzi et al.. Vasa, 2025. Evidence type: Systematic review of six studies involving 115 women Limitation: Exercise appeared promising for symptoms, quality of life and function, often with larger effects when compression was also used; studies were small and heterogeneous. PubMed DOI
- [lundanes-2024] Effect of a low-carbohydrate diet on pain and quality of life in female patients with lipedema: a randomized controlled trial Julianne Lundanes et al.. Obesity, 2024. Evidence type: Eight-week randomized controlled diet trial in 70 women with lipedema and obesity Limitation: The low-carbohydrate group had greater weight loss and a larger reduction in current pain than the control diet group. The trial was short and does not establish a curative diet for lipedema. PubMed DOI
- [deoliveira-2025] Clinical or cultural? Dietary interventions for lipedema: a systematic review Jônatas de Oliveira et al.. Maturitas, 2025. Evidence type: Systematic review of nine studies involving 269 women Limitation: High heterogeneity, small samples and risk of bias prevented a meta-analysis; the review concluded that the effects of dietary approaches remain unclear. PubMed DOI
Editorial source review
This section shows how the article's key factual claims are linked to the source.
Phrasings that require caution
- Lipedema is not diagnosed by this article or by TwinPare.
- Do not describe hormones, diet, exercise or any single gene as a proven cause or cure.
- The discordant identical-twin report is a single congress case and should be treated as hypothesis-generating evidence.
- People with pain, swelling or disproportionate limb changes should seek qualified clinical assessment.
| ID | Claim | Source support | Caution |
|---|